In summary, for patients with MD, dexamethasone combined with gentamicin can reduce the expression levels of myelin P0 protein antibodies and the incidences of vertigo, tinnitus, and gait instability, but with no effect on efficacy and number of vertigo attacks 6 months after treatment. The gene discussed is MPZ; the disease is Tinnitus.